Your browser doesn't support javascript.
loading
Distinguishing Drug from Disease by Use of the Hydrashift 2/4 Daratumumab Assay.
Thoren, Katie L; Pianko, Matthew J; Maakaroun, Youssef; Landgren, C Ola; Ramanathan, Lakshmi V.
Afiliação
  • Thoren KL; Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; thorenk@mskcc.org.
  • Pianko MJ; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Maakaroun Y; Sebia Inc., Norcross, GA.
  • Landgren CO; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Ramanathan LV; Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
J Appl Lab Med ; 3(5): 857-863, 2019 03.
Article em En | MEDLINE | ID: mdl-31639760
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas do Mieloma / Imunoensaio / Imunoeletroforese / Anticorpos Monoclonais / Mieloma Múltiplo Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas do Mieloma / Imunoensaio / Imunoeletroforese / Anticorpos Monoclonais / Mieloma Múltiplo Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article